Jerry Ling has earned multiple distinctions for his work leading high-stakes corporate investigations into the most significant forms of misconduct, ranging from trade secret theft and embezzlement, to potential violations of the Foreign Corrupt Practices Act (FCPA), the False Claims Act (FCA), and cybersecurity laws. He has also litigated intellectual property and contractual disputes in Asia and in the United States.
Jerry has arbitrated breach of contract claims for a global private equity fund in Hong Kong, defended a major telecom manufacturer against patent infringement lawsuits filed in China, and brought trade secret claims on behalf of a global retailer in coordinated actions across Asia. He also handles matters in U.S. courts and recently assisted a technology company in an antitrust dispute and an investment fund in a consumer class action.
Jerry was previously based in Shanghai for 10 years and counseled dozens of U.S.-listed companies in investigating alleged compliance violations arising in China and Asia. Notably, he recently assisted public companies in obtaining declinations from U.S. government authorities after self-disclosing alleged FCPA and other compliance violations.
Jerry also leads risk assessments and compliance training for multinationals — with a focus on anticorruption, cybersecurity, and data privacy laws — and advises clients with respect to conducting anticorruption and compliance due diligence for their global acquisitions.
Experience
Speaking Engagements
- September 26, 2019
Chinese Companies and the FCPA: What Type of Case is Likely to be the First U.S. FCPA Investigation of a Chinese Company? - May 1, 2019
Cybersecurity and Privacy Laws in China and Asia - May 15, 2018
Life Science Seminar: Anti-corruption Regulations - May 15, 2018
Life Science Seminar: PRC Privacy, State Secret and Cybersecurity Laws - March 30, 2018
ACFE Spring Conference 2018: Fraud Investigative Training Workshop - Ask the Experts! - October 11, 2017
What to Do When . . . Your Company Confronts Anti-Corruption Issues in China or India: The Increasing Coordination of U.S. and International Law Enforcement - October 2016
Business Beyond Borders: What You Need to know about Anti Bribery and Corruption in Asia-Pacific - January 26, 2016
CLE Academy Shanghai 2016 - December 9, 2015
Global Corruption Risks and Best Practices for the Life Sciences Industry - September 17, 2015
Jones Day Life Science Seminar: Off Label Promotion and FCA Claims; Corruption - June 8-9, 2015
SEC Conference 2015: Update on SEC Enforcement Initiatives for Asia Based Companies - June 17, 2014
SEC Conference 2014: An Accounting and Reporting Update for US Listed Companies Panel speaker for Corporate Fraud & Other Litigation Issues in China - May 6, 2014
The Continuing Expansion of Health Care Enforcement by U.S. and International Authorities: Key Developments and Implications for the Future - December 19-20, 2013
SEC Conference 2013: An Accounting & Reporting Update for US Listed Companies: 1) Update on SEC Enforcement Initiatives for Asia-Based Companies 2) Corporate Fraud in China: Designing & Implementing Effective Anti-Corruption Programs 3) Corporate Fraud in China: Foreign Corrupt Practices Act & Chinese Companies - December 12, 2013
Shanghai In-house Counsel Forum: General Counsel Roundtable - Complying with Data Privacy and State Secrets Laws in Cross-Border Investigations and M&A - December 4, 2013
Daimler Construction Compliance Workshop - October 25,2013
Duke Journal of Comparative and International Law Symposium on Investment in Emerging Markets:The Challenges of Infrastructure Development, Assessing and Protecting against Corruption and other Investment Risks - August 28, 2013
FCPA Roundtable - May 3, 2013
Doing Business in China: Understanding Corruption Risks and Compliance Challenges in China - April 30, 2013
Doing Business in China: Understanding Corruption Risks and Compliance Challenges in China - 2012年10月25日
在华投资研讨会:外商对华投资新的挑战和机遇 - October 25, 2012
China Inbound Seminar: New Challenges and Opportunities for Foreign Investments in China - October 24, 2012
Outbound Seminar "Managing Legal Risks in Global Expansion of Chinese Companies" - 2012年10月23日
生命科学法律剧 - October 23, 2012
Life Science Legal Drama - "Mr. Big in Wonderland" - May 5, 2012
M&A in China: Conducting FCPA Due Diligence and Creating an Effective and Practical Post-Closing Compliance Policy, 2nd CCH In-House Legal Conference - April 12, 2012
Due Diligence & Business Valuation in M&A Deals 2012: Conducting Corruption Due Diligence for M&A Deals in China
"I think he's fantastic."Chambers Asia-Pacific
- Harvard University (J.D. magna cum laude 2003); Dartmouth College (A.B. in Biology magna cum laude 2000)
- California; Hawaii; U.S. District Courts for the Central, Eastern, Northern, and Southern Districts of California and District of Hawaii; and U.S. Court of Appeals for the Ninth Circuit
The Legal 500 Asia Pacific — top-tier recommendation: China: dispute resolution
Chambers Asia-Pacific — recognized in the area of corporate investigation, where he attracts plaudits from numerous sources, with one revealing that "he's thorough, he's practical, he's a very good investigator, and he's client-centric," while another simply says, "I think he's fantastic"
- Law Clerk to the Honorable Richard R. Clifton, United States Court of Appeals, Ninth Circuit (2003-2004)
- Mandarin